Stratos Wealth Partners LTD. Boosts Stock Holdings in Cigna Group $CI

Stratos Wealth Partners LTD. grew its position in shares of Cigna Group (NYSE:CI) by 10.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,615 shares of the health services provider’s stock after acquiring an additional 543 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Cigna Group were worth $1,856,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of CI. Flaharty Asset Management LLC purchased a new position in Cigna Group during the 1st quarter worth $28,000. 1248 Management LLC purchased a new position in Cigna Group during the 1st quarter worth $29,000. Activest Wealth Management grew its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares during the period. Retirement Wealth Solutions LLC increased its position in shares of Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Finally, Saudi Central Bank purchased a new stake in shares of Cigna Group during the 1st quarter valued at $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Cigna Group Price Performance

Shares of NYSE:CI opened at $307.03 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $81.96 billion, a PE ratio of 16.76, a P/E/G ratio of 0.88 and a beta of 0.45. Cigna Group has a twelve month low of $256.89 and a twelve month high of $350.00. The company has a 50-day moving average price of $297.87 and a two-hundred day moving average price of $307.81.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Barclays raised their target price on Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. TD Cowen raised Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $369.89.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.